Spectrum Planning & Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Spectrum Planning & Advisory Services’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Hold	3,350	–	–	0.45%	44
2026 Q1	$1.11M	Hold	3,350	–	–	0.55%	38
2025 Q4	$1.33M	Hold	3,350	–	–	0.69%	34
2025 Q3	$1.53M	Sell	3,350 -9	-0.3%	-$3.67K	0.86%	31
2025 Q2	$1.1M	Hold	3,359	–	–	0.71%	34
2025 Q1	$907K	Hold	3,359	–	–	0.76%	28
2024 Q4	$790K	Hold	3,359	–	–	0.69%	26
2024 Q3	$924K	Sell	3,359 -201	-6%	-$52.3K	0.89%	21
2024 Q2	$879K	Buy	+3,560	New	+$562K	0.85%	22
2023 Q4	$681K	Hold	3,560	–	–	0.97%	24
2023 Q3	$630K	Sell	3,560 -31	-0.9%	-$5.92K	0.99%	22
2023 Q2	$681K	Hold	3,591	–	–	1.02%	20
2023 Q1	$719K	Hold	3,591	–	–	1.17%	18
2022 Q4	$853K	Sell	3,591 -44	-1%	-$9.38K	1.16%	22
2022 Q3	$728K	Hold	3,635	–	–	0.74%	25
2022 Q2	$530K	Hold	3,635	–	–	0.55%	30
2022 Q1	$594K	Hold	3,635	–	–	0.54%	30
2021 Q4	$616K	Hold	3,635	–	–	0.56%	31
2021 Q3	$686K	Hold	3,635	–	–	0.67%	29
2021 Q2	$616K	Hold	3,635	–	–	0.59%	31
2021 Q1	$513K	Hold	3,635	–	–	0.53%	31
2020 Q4	$472K	Buy	+3,635	New	+$485K	0.51%	31

Other funds holding ALNY

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

PSC

Portman Square Capital London, United Kingdom $2.11B AUM 19.71% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Spectrum Planning & Advisory Services's ALNY Position: Q2 2026 in Review

Spectrum Planning & Advisory Services held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 3,350 shares worth $1.01M. The position accounts for 0.45% of the portfolio, ranked #44.

Spectrum Planning & Advisory Services first reported a position in ALNY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.53M in Q3 2025. 78 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Spectrum Planning & Advisory Services held 3,350 shares of Alnylam Pharmaceuticals worth $1.01M as of Q2 2026.
Spectrum Planning & Advisory Services left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
Alnylam Pharmaceuticals made up 0.45% of Spectrum Planning & Advisory Services's portfolio in Q2 2026, its #44 holding.
Spectrum Planning & Advisory Services first reported a position in Alnylam Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
Spectrum Planning & Advisory Services's Alnylam Pharmaceuticals position peaked at $1.53M in Q3 2025.
78 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Spectrum Planning & Advisory Services's 13F filing for Q2 2026, filed 14 Jul 2026.